Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis.

Infants and young children with CF and SHSe have altered AA metabolism and dysregulated inflammatory gene expression resulting in impaired bacterial clearance. Our findings identified potential therapeutic targets to halt early disease progression associated with SHSe in the young population with CF.